Plasma CRABP2 as a Novel Biomarker in Patients with Non-Small Cell Lung Cancer
Open Access
- 1 January 2018
- journal article
- research article
- Published by XMLink in Journal of Korean Medical Science
- Vol. 33 (26) , e178
Abstract
Kim DJ, et al. J Korean Med Sci. 2018 May;33(26):e178. https://doi.org/10.3346/jkms.2018.33.e178Keywords
Funding Information
- Ministry for Health and Welfare (1631210)
This publication has 26 references indexed in Scilit:
- Next-Generation Sequencing: Methodology and ApplicationJournal of Investigative Dermatology, 2013
- Proteomic Portrait of Human Breast Cancer Progression Identifies Novel Prognostic MarkersCancer Research, 2012
- Proteomic characterization of ovarian cancers identifying annexin‐A4, phosphoserine aminotransferase, cellular retinoic acid‐binding protein 2, and serpin B5 as histology‐specific biomarkersCancer Science, 2012
- Aberrant Expression of Retinoic Acid Signaling Molecules Influences Patient Survival in Astrocytic GliomasThe American Journal of Pathology, 2011
- Retinoid pathway and cancer therapeuticsAdvanced Drug Delivery Reviews, 2010
- Comparative proteomic analysis of differentially expressed proteins in primary retinoblastoma tumorsProteomics – Clinical Applications, 2010
- Gene Expression Signature of Cigarette Smoking and Its Role in Lung Adenocarcinoma Development and SurvivalPLOS ONE, 2008
- Opposing Effects of Retinoic Acid on Cell Growth Result from Alternate Activation of Two Different Nuclear ReceptorsCell, 2007
- Cellular Retinoic Acid–Binding Protein II Is a Direct Transcriptional Target of MycN in NeuroblastomaCancer Research, 2006
- Direct Channeling of Retinoic Acid between Cellular Retinoic Acid-Binding Protein II and Retinoic Acid Receptor Sensitizes Mammary Carcinoma Cells to Retinoic Acid-Induced Growth ArrestMolecular and Cellular Biology, 2002